Need Help?

Single cell transcriptome atlas of immune cells in human small intestine and in Celiac disease

Single cell transcriptome atlas of immune cells in human small intestine and in Celiac disease

Request Access

CIR_RIMLS_DAA_

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom XXXXX grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: XXXXX and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics in Immunological mechanisms for celiac disease, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. XXXXX: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution is responsible for obtaining all necessary approvals in according to own national legislation before request for access to the data, including provide documentation for such approvals. 3. The User Institution agrees to preserve, at all times, the confidentiality of these Data in accordance to applicable legislation concerning protection of personal data protection. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 4. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 5. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 6. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 7. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 8. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 9. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 10. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 11. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 12. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 13. The User Institution will notify XXXXX within 30 days of any changes or departures of Authorised Personnel. 14. The User Institution will notify XXXXX prior to any significant changes to the protocol for the Project. 15. The User Institution will notify XXXXX as soon as it becomes aware of a breach of the terms or conditions of this agreement. 16. XXXXX may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 17. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than XXXXX. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 18. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 19. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 20. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002531267 fastq.gz 1.5 GB
EGAF00002531268 fastq.gz 617.3 MB
EGAF00002531269 fastq.gz 2.0 GB
EGAF00002531270 fastq.gz 842.1 MB
EGAF00002531271 fastq.gz 834.7 MB
EGAF00002531272 fastq.gz 349.3 MB
EGAF00002531273 fastq.gz 1.9 GB
EGAF00002531274 fastq.gz 814.0 MB
EGAF00002531275 fastq.gz 896.8 MB
EGAF00002531276 fastq.gz 377.7 MB
EGAF00002531277 fastq.gz 1.7 GB
EGAF00002531278 fastq.gz 734.0 MB
EGAF00002531279 fastq.gz 1.3 GB
EGAF00002531280 fastq.gz 515.8 MB
EGAF00002531281 fastq.gz 1.6 GB
EGAF00002531282 fastq.gz 658.4 MB
EGAF00002531283 fastq.gz 1.1 GB
EGAF00002531284 fastq.gz 470.9 MB
EGAF00002531285 fastq.gz 1.3 GB
EGAF00002531286 fastq.gz 573.6 MB
EGAF00002531287 fastq.gz 1.3 GB
EGAF00002531288 fastq.gz 586.8 MB
EGAF00002531289 fastq.gz 164.5 MB
EGAF00002531290 fastq.gz 87.3 MB
EGAF00002531291 fastq.gz 133.9 MB
EGAF00002531292 fastq.gz 69.9 MB
EGAF00002531293 fastq.gz 1.3 GB
EGAF00002531294 fastq.gz 531.8 MB
EGAF00002531295 fastq.gz 3.0 GB
EGAF00002531296 fastq.gz 1.3 GB
EGAF00002531297 fastq.gz 3.9 GB
EGAF00002531298 fastq.gz 1.6 GB
EGAF00002531299 fastq.gz 3.5 GB
EGAF00002531300 fastq.gz 1.5 GB
EGAF00002531301 fastq.gz 2.0 GB
EGAF00002531302 fastq.gz 798.0 MB
EGAF00002531303 fastq.gz 2.0 GB
EGAF00002531304 fastq.gz 803.0 MB
EGAF00002531305 fastq.gz 2.3 GB
EGAF00002531306 fastq.gz 937.0 MB
EGAF00002531307 fastq.gz 3.0 GB
EGAF00002531308 fastq.gz 1.2 GB
EGAF00002531309 fastq.gz 2.2 GB
EGAF00002531310 fastq.gz 862.0 MB
EGAF00002531311 fastq.gz 889.0 MB
EGAF00002531312 fastq.gz 438.9 MB
EGAF00002531313 fastq.gz 1.8 GB
EGAF00002531314 fastq.gz 791.3 MB
EGAF00002531315 fastq.gz 835.0 MB
EGAF00002531316 fastq.gz 334.4 MB
EGAF00002531317 fastq.gz 1.8 GB
EGAF00002531318 fastq.gz 726.3 MB
EGAF00002531319 fastq.gz 672.8 MB
EGAF00002531320 fastq.gz 283.6 MB
EGAF00002531321 fastq.gz 2.1 GB
EGAF00002531322 fastq.gz 905.6 MB
EGAF00002531323 fastq.gz 758.1 MB
EGAF00002531324 fastq.gz 315.1 MB
EGAF00002531325 fastq.gz 1.9 GB
EGAF00002531326 fastq.gz 800.9 MB
EGAF00006263609 1656414921797 534.2 MB
EGAF00006263610 1656414921797 482.6 MB
EGAF00006263611 1656414921797 670.3 MB
EGAF00006263612 1656415821452 614.8 MB
EGAF00006263613 1656414921797 601.2 MB
EGAF00006263614 1656414921797 591.8 MB
EGAF00006263615 1656414921797 536.4 MB
EGAF00006263616 1656414921797 509.0 MB
EGAF00006263617 1656415821452 571.1 MB
EGAF00006263618 1656414921797 565.8 MB
EGAF00006263619 1656414921797 599.0 MB
EGAF00006263620 1656414921797 532.9 MB
EGAF00006263621 1656415821452 685.6 MB
EGAF00006263622 1656414921797 655.7 MB
EGAF00006263623 1656414921797 523.3 MB
EGAF00006263624 1656414921797 507.0 MB
EGAF00006263625 1656414921797 601.4 MB
EGAF00006263626 1656414921797 556.4 MB
EGAF00006263627 1656414921797 534.3 MB
EGAF00006263628 1656414921797 467.4 MB
EGAF00006263629 1656414921797 535.8 MB
EGAF00006263630 1656414921797 475.6 MB
EGAF00006263631 1656414921797 632.5 MB
EGAF00006263632 1656414921797 583.5 MB
EGAF00006263633 1656415821452 637.3 MB
EGAF00006263634 1656414921797 587.4 MB
EGAF00006263635 1656414921797 439.0 MB
EGAF00006263636 1656414921797 389.4 MB
EGAF00006263637 1656414921797 651.6 MB
EGAF00006263638 1656415821452 586.4 MB
90 Files (87.3 GB)